Bactériémies associées aux cathéters veineux centraux chez les receveurs canadiens de cellules souches sanguines : coûts connexes

Melanie Keeler, Barbara K. Haas, Michael Nieswiadomy, Charles McConnel, Sally Northam, Lynn Savoie

Abstract


Problème : Les bactériémies associées aux cathéters veineux centraux (BACC)sont liées à un accroissement des coûts en soins de santé et de la morbidité chez les patients. La présente étudeavait pour but d’estimer les frais directs en milieu hospitalier liés à la BACC chez les receveurs de greffe de sang et de moelle au Canada munis d’un cathéter veineux central (CVC) tunnellisé.

thode :Une comparaison cas-témoins de dossiers de patients d’un seul centre a été réalisée. Les dossiers indiquant une BACC ont été appariés à des dossiers de patients n’indiquant aucune BACC à des fins de comparaison dans les domaines suivants : durée du séjour, examens de laboratoire, examens diagnostiques, médicaments employés, consultations avec un médecin spécialiste, frais de remplacement des cathéters, et enfin, durée du séjour dans l’unité de soins intensifs.

Résultats : Les sujets atteints de bactériémie restaient en moyenne 19,37jours de plus à l’hôpital. Les frais supplémentaires associés au diagnostic et au traitement de la BACC s’élevaient à 4739,95 $ en moyenne. Selon les estimations, le fardeau financier total de la BACC dans le domaine de la greffe de sang et de moelle du Canada pour l’exercice 2013 se montait à 44 816,48 $parincident. De plus, les infections duisaient la durée d’utilisation des cathéters de 18,68jours, en moyenne.

Mots clés : bactériémies associées aux cathéters veineux centraux [BACC],coûts, greffes de cellules souches


Full Text:

PDF

References


Bereket, W., Hemalatha, K., Getenet, B., Wondwossen, T., Solomon, A., Zeynudin, A., & Kannan, S. (2012). Update on bacterial nosocomial infections. European review for Medical and Pharmacological Sciences, 16, 1039–1044.

Boersma, R.S., & Schouten, H.C. (2010). Clinical practices concerning central venous catheters in haematological patients. European Journal of Oncology Nursing, 14, 200–214.

Center for Disease Control and Prevention. (2012). Device associated module CRBSI. Retrieved from http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf

Dal Forno, C., Correa, L., Scatena, P., Silva, C., Shiramizo, S., Pavão dos Santos, O., ... Sardenberg, C. (2012). Bloodstream infection in the intensive care unit: Preventable adverse events and cost savings. Value In Health Regional Issues, 1(2), 136.

Dibb, M., Carlson, G., Abraham, A., Shaffer, J., Teubner, A., & Lal, S. (2012). OC-034 salvage of central venous catheters in HPN catheter-related blood stream infections is safe and effective: 18 years of experience from a national centre. GUT, 61, A14–A15.

Higuera, F., Sigfrido, R.F., Rosenthal, V.D., Soto, J.M., Castanon, J., Franco, G., … Graves, N. (2007). Attributable cost and length of stay for patients with central venous catheter–associated bloodstream infection in Mexico City intensive care units: A prospective, matched analysis. Infection Control and Hospital Epidemiology, 28(1), 31–35.

Hsu, E., Lin, D., Samuel, J.E., Kamran, S.H, Frick, K.D., Pronovost, P.J., & Pham, J.C. (2013). Doing well by doing good. Assessing the cost savings of an intervention to reduce central line-associated bloodstream infection in a Hawaii hospital. American Journal of Medical Quality, Advance online publication. doi 10.1177/1062860613486713

International Business Machines Corporation. (2012). Statistical package for the social sciences v.21. USA: Microsoft Corp.

Joint Commission. (2012). Preventing central line-associated bloodstream infections: A global challenge, a global perspective. Oak Brook, IL: Joint Commission Resources. Retrieved from http://www.PreventingCRBSIs.pdf

Khadem, T.M., Dodds Ashley, E., Wrobel, M., & Brown, J. (2012). Antimicrobial stewardship: A matter of process or outcome? Pharmacotherapy, 32(8), 688–706.

Liu J.W., Su Y.K., Liu, C.F., & Chen, J.B. (2002). Nosocomial blood‐stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. Journal of Hospital Infection, 50, 224–227.

Loi canadienne sur la santé, L.R.C., ch. C-6 (1985).

Mermel, L.A., Allon, M., Bouza, E., Craven, D.E., Flynn, P., O’Grady, N., … Warren, D.K. (2009). Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clinical Infectious Disease, 49(1), 1–45.

Nicholson, W., & Snyder, C. (2012). Microeconomic Theory: Basic principles and extensions. (11th ed.). Independence: South-Western Cengage Learning.

O’Grady, N.P., Alexander, M., Burns, L.A., Dellinger, E.P., Garland, J., O’Heard, S, … Saint, S. (2011). Guidelines for the prevention of intravascular catheter-related infections. American Journal of Infection Control, 39, S1–34.

Orsi, G.B., Di Stefano, L., & Noah, N. (2002). Hospital-acquired, laboratory-confirmed bloodstream infection: Increased hospital stay and direct costs. Infection Control and Hospital Epidemiology, 23, 190–197.

Patrick, S.E., Davis, M.M., Sedman, A.B., Meddings, J.A., Hieber, S., Lee, F.M., … Schumacher, R.E. (2013). Accuracy of hospital administrative data in reporting central line associated bloodstream infections in newborns. Pediatrics, 13(1), S75–80

Raschka, S., Dempster, L., & Bryce, E. (2013). Health economic evaluation of an infection prevention and control program: Are quality and patient safety programs worth the investment? American Journal of Infection Control, 41(9), 773–777.

Rosenthal, V.D., Guzman, S, Migone, O., & Crnich, C.J. (2003). The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. American Journal of Infection Control, 31(8), 475–480.

Safdar, N., Fine, J.P., & Maki, D.G. (2005). Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection. Annals of Internal Medicine, 142, 451–466.

Santé Canada. (2013). Rapport annuel de 2012–2013 sur l’application de la Loi canadienne sur la santé. Récupéré du site Web de Santé Canada à http://www.hc-sc.gc.ca/hcs-sss/pubs/cha-lcs/index-fra.php

Santerre, R.E., & Neun, S.P. (2010). Health economics: Theory, insights, and industry studies. Mason, OH: Cengage Learning.

Scales, K. (2011). Reducing infection associated with central venous access devices. Nursing Standard, 25(36), 49–56.

Shannon, R. P, Bhavin, P., Cummins, D., Shannon, A.H., Ganguli, G., & Yee, L. (2006). Economics of central line-associated bloodstream infections. American Journal of Medical Quality, 21(6), 7S–16.

Tarricone, R., Torbica, A., Franzetti, F., & Rosenthal, V.D. (2010). Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed versus open infusion containers. The case of intensive care units in Italy. Cost Effectiveness Resource Allocation, 8(8). doi:10.1186/1478-7547-8-8

Tomblyn, M., Chiller, T., Einsele, H., Sepkowitz, K., Storek, J., & Boeckh, M.A. (2009). Guideliens for preventing infectious complications among hematapoietic cell transplant receipients: A global perspective. Biology Blood Marrow Transplant, 15, 1143_1238.

Yasuhiko, T., Borlee, B.R., O’Conner, J.R., Hill, P.J., Harwood, C.S, Wozniak, D.J., & Parsek, M.R. (2012). Self-produced exopolysaccharide is a signal that stimulates biofilm formation in Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences of the United States of America, 109(50), 20632–20636.


Refbacks

  • There are currently no refbacks.